8-K/A XBRL

FORM 8-K/A

Company: Vistagen Therapeutics, Inc.
Filed: November 7, 2023
Period of Report: November 2, 2023
Accession Number: 0001437749-23-030460

View Document ↗ View on SEC.gov ↗